Healthcare: Pharmaceuticals - Press Releases

Anecdotal and Scientific Evidence Suggest Curcumin Has the Potential to Combat Diseases

A wide variety of diseases are continually affecting the lives of millions of people. The good news is that many of the prevalent medical conditions nowadays are possibly preventable through practicing a healthy diet and lifestyle, or consuming some dietary supplements such as turmeric.

New Report Available: Global Statin Market 2015-2019

LogoStatin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.

Research Reveals the Positive Effects of Turmeric for Ischemic Stroke

Strokes take place when there is a restriction in the blood flow of the brain, and the brain tissue is deprived of nutrients and oxygen for a few seconds. There are two types of stroke, and one is Ischemic stroke.

Medicortex Developing New Biomarker Diagnostic Tools to Gauge Severity and Extent of Traumatic Brain Injuries and Strokes

LogoMedicortex Finland Oy has established a new diagnostic division/arm to its core business with the goal of developing a biomarker diagnostic test that would reliably establish the severity and extent of brain injuries. The companion diagnostic will be coupled with Medicortex's signature pharmaceutical therapy that will limit the long-term effects of brain injuries, including the types of severe brain trauma that leads to strokes in patients.

"Multiple Sclerosis Market in the US 2015-2019" Published

LogoMultiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Multiple sclerosis can be broadly classified into four types: RRMS, SPMS, PPMS, and PRMS.

InnerWhealth Solutions Launch Their Healthy and Lustrous Hair Boost to Stop Hair Loss on Amazon

35 million men and 21 million women in the US are experiencing the thinning of hair and hair loss. InnerWhealth Solutions has launched a natural product that will help to combat hair loss. The product provides healthy hair growth support at the cellular level by nourishing hair follicles.

Pharmacy Automation Market 2015 Review, Research, Trends, Industry Size, Share and Forecast 2019

LogoGlobal Pharmacy Automation market to grow at a CAGR of 7.01 percent over the period 2014-2019. Pharmacy automation system is an effective tool to minimize prescription errors and ensure patient safety. It is a system to automate workflow process and eliminate medication errors during packaging and dispensing in the field of medicine and healthcare. Pharmacy automation involves medicine counting, mixing and measuring liquids and powders for compounding, updating customer database, and inventory management. While maintaining accuracy level, the system can bring new business without hiring and training new staff.

Just Published: "Global Hyperphosphatemia Drugs Market 2015-2019"

LogoPhosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.

Global Plasma Therapeutics Market 2015-2019 - New Study Released

LogoPlasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases. The separation of plasma from the blood is done by a process known as plasmapheresis. Plasma therapeutics are utilized in the treatment of rare, life-threatening, chronic, and genetic diseases, such as immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, and infectious diseases such as tetanus, hepatitis, and rabies.

Global Membrane Market in Pharmaceutical Industry 2015-2019 - New Report Available

LogoMembranes are a type of selective barrier that are primarily used for separation or concentration of the feed stream. The feed stream is passed through the membrane that selectively allows some constituents to pass, while others are retained back on the surface of the membrane, depending on its pore size. The constituents that are allowed to pass are known as permeate and the ones retained back are known as concentrate or retentate. Different types of membrane are used in the pharmaceutical industry depending on their pore size. There are many technologies implemented for these membranes, including ultrafiltration, microfiltration, reverse osmosis, and nanofiltration.

Key Executive with Significant Hematology Drug Development Expertise Joins Actinium Pharmaceuticals as Head of Clinical Development

Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today the appointment of Felix Garzon, MD, Ph.D. to the position of Senior Vice President, Head of Clinical Development effective August 17, 2015. Dr. Garzon brings with him 28 years of pertinent pharmaceutical and biotechnology experience in increasingly senior roles, most recently at Eisai and Bristol-Myers Squibb, having worked on both later and earlier stages of drug development.

Global Human Insulin Market to Grow at a CAGR of 10.29% Through 2019

LogoInsulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.

Compounding Pharmacy Services Require Maximum Licensing, Says Provider

Recent incidents that question the integrity of compounded drugs administered to subjects in several cities reinforces the need for fuller licensing and fraud control for all such companies, say representatives for AbsoluteRX, a Lutz, Florida based firm and website. The call for tighter approval comes in the wake of cases such as the Moses Lake compounded pharmacy in Washington in late July, who recalled unexpired human and veterinary compounded drugs due to concerns about their sterility. The US government also reached a settlement with a Jacksonville pharmacy in July for $8.4 million, to resolve allegations of unscrupulous practices by that facility.

XareltoCares a Leading Blog on Xarelto Launched

XareltoCares.com is a newly launched website that has been established to inform readers of Xarelto blood thinner uses and bleeding side effects. The main objective of the website is to spread knowledge and educate people to empower them to take informed decisions when regarding the popular blood thinning drug use. The website is being managed by a group of writers who have accumulated a vast range of information through impressive research skills allow them to search out the answers to the most pressing concerns about the use and side effects of Xarelto. The blog recently shared an article about Xarelto Lawsuits that were filed as a result of the side effects caused by the drug.

New Market Research Report: Candidiasis Global Clinical Trials Review, H1, 2015

LogoGlobalData's clinical trial report, "Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Recent Study: Epistaxis Global Clinical Trials Review, H1, 2015

LogoGlobalData's clinical trial report, "Epistaxis Global Clinical Trials Review, H1, 2015" provides an overview of Epistaxis clinical trials scenario. This report provides top line data relating to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Nasal Obstruction Global Clinical Trials Review, H1, 2015 - New Study Released

LogoGlobalData's clinical trial report, "Nasal Obstruction Global Clinical Trials Review, H1, 2015" provides an overview of Nasal Obstruction clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Brain Injury Global Clinical Trials Review, H1, 2015 - New Market Study Published

LogoGlobalData's clinical trial report, "Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

New Report Available: Autoimmune Diseases Market in the US 2015-2019

LogoAutoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.

"Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation" Is Now Available at Fast Market Research

LogoPancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and improved approaches to treatment, which is not being met by the current market.

Beuses USA Inc. Launches Online Training Videos on How to Become a Pharmaceutical Sales Rep

For all those people who wish to make a career in pharmaceutical or medical sales, www.howtogetintopharmaceuticalsales.com/ has several useful videos to help the purpose. These contain step by step methods which have been proved to be effective in the field and since there is a lot of competition in this field, they can be considered by those who want to break in.

The General Partition Company Builds Box Dividers and Partitions for Pharmaceutical Companies

Based in Pennsylvania, very conveniently located around the industry-rich Croydon region, the General Partition Company provides a wide variety of box dividers, separators and partitions that are specialized for each industry contracting services with them. Right now, the company is announcing that they are available to provide box partitions and dividers specifically for the pharmaceutical industry.

Actinium Advances Iomab-B Towards Phase 3 with Pre-IND Meeting Request

Actinium Pharmaceuticals, Inc.("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has submitted a request for a pre-IND (Investigative New Drug) meeting to the U.S. Food and Drug Administration (FDA) for the company's Iomab-B drug candidate currently preparing to commence the pivotal Phase 3 trial. During the early development of a new drug, manufacturers are required to apply for and obtain IND designation.

Georgia Prescription Drug Abuse Prevention Initiative Awareness Campaign "Prescription Drug Abuse - It's Not What the Doctor Ordered"

LogoAccording to the Centers for Disease Control and Prevention (CDC) in 2014, "46 people die from an overdose of prescription (Rx) painkillers in the United States, each day." Can you imagine getting the news that a friend or family member died from an Rx drug overdose? You can do something about this now! The Georgia Prescription Drug Abuse Prevention Initiative (GPDAPI) of The Council on Alcohol and Drugs, with guidance and funding provided by the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD), asks you to take two actions to address Rx drug abuse. First "lock up" your Rx drugs so only you can access and dispense them. Secondly, dispose of your unwanted, unneeded, or out of date, Rx drugs at any one of the almost 200 drug drop boxes in Georgia which are located in secure law enforcement facilities.

Catholic Bishops Oppose Big Pharma's Patent Abuses in South Africa

The Justice and Peace Commission for the Southern African Catholic Bishops' Conference (SACBC) has raised serious concerns about patent laws in South Africa that severely diminish the financial capacity of the health department to purchase new and more effective drugs for the public health care.